ClearPoint Neuro, Inc. (NasdaqCM:CLPT) will look for acquisitions. The company announced the pricing of its underwritten public offering of 2,307,694 shares of its common stock at a price to the public of $6.50 per share. The Company intends to use the net proceeds from this offering for general corporate purposes, which may include research and development expenditures, potential acquisitions of or investments in business, products and technologies that complement the Company's business, or repayment of the Company's indebtedness.